Home » NIH, Research Groups Submit Dx, Biomarker IP to 'Patent Supermarket' for Non-Exclusive Licensing

NIH, Research Groups Submit Dx, Biomarker IP to 'Patent Supermarket' for Non-Exclusive Licensing

Oct 03, 2012
|
Turna Ray
Premium

Several high-profile research organizations, including the National Institutes of Health, have contributed a number of personalized medicine-focused biomarker- and diagnostics-related patents to a new intellectual property licensing "supermarket" called Librassay.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

A Butterfly's Wings

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

Best Options

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

This Week in PNAS

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

What's Popular?

In Diagnostics

  1. Ambry Genetics, FDNA Ink Deal to Integrate Technologies

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.